HK1255052A1 - 豬科動物物種中增强的免疫應答 - Google Patents

豬科動物物種中增强的免疫應答

Info

Publication number
HK1255052A1
HK1255052A1 HK18114176.7A HK18114176A HK1255052A1 HK 1255052 A1 HK1255052 A1 HK 1255052A1 HK 18114176 A HK18114176 A HK 18114176A HK 1255052 A1 HK1255052 A1 HK 1255052A1
Authority
HK
Hong Kong
Prior art keywords
immune response
enhanced immune
porcine species
porcine
species
Prior art date
Application number
HK18114176.7A
Other languages
English (en)
Inventor
Albert Abraham
Jason Nickell
Daniel Keil
Christian Weiss
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of HK1255052A1 publication Critical patent/HK1255052A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK18114176.7A 2015-07-31 2018-11-07 豬科動物物種中增强的免疫應答 HK1255052A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562199848P 2015-07-31 2015-07-31
PCT/EP2016/067971 WO2017021266A1 (en) 2015-07-31 2016-07-28 Enhanced immune response in porcine species

Publications (1)

Publication Number Publication Date
HK1255052A1 true HK1255052A1 (zh) 2019-08-02

Family

ID=56682095

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18114176.7A HK1255052A1 (zh) 2015-07-31 2018-11-07 豬科動物物種中增强的免疫應答

Country Status (18)

Country Link
US (1) US11439703B2 (zh)
EP (1) EP3328424A1 (zh)
JP (1) JP2018521109A (zh)
KR (1) KR20180036765A (zh)
CN (1) CN108025062A (zh)
AR (1) AR105568A1 (zh)
AU (1) AU2016302436B2 (zh)
BR (1) BR112018002107A2 (zh)
CA (1) CA2993883A1 (zh)
CL (1) CL2018000253A1 (zh)
HK (1) HK1255052A1 (zh)
IL (1) IL256984A (zh)
MX (1) MX2018001251A (zh)
PH (1) PH12018500201A1 (zh)
SG (1) SG10202000891UA (zh)
TW (1) TW201718001A (zh)
WO (1) WO2017021266A1 (zh)
ZA (1) ZA201801338B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031778A1 (en) 2016-07-26 2018-02-01 Bayer Animal Health Gmbh Increased fertility in bovine species
CN116916949A (zh) * 2020-10-02 2023-10-20 伊穆农股份有限公司 多核苷酸疫苗及其使用方法
WO2023224882A1 (en) * 2022-05-17 2023-11-23 Elanco Us Inc. Methods for predicting efficacy of a modified live porcine reproductive and respiratory syndrome virus (prrsv) vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6339068B1 (en) * 1997-05-20 2002-01-15 University Of Iowa Research Foundation Vectors and methods for immunization or therapeutic protocols
US20040247662A1 (en) 1998-06-25 2004-12-09 Dow Steven W. Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
ATE272410T1 (de) 1999-03-26 2004-08-15 Vical Inc Adjuvanszusammensetzungen zur erhöhung der immunantwort auf polynukleotid-basierende impfstoffe
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
US20040002472A1 (en) 2000-01-21 2004-01-01 Audonnet Jean-Christophe Francis Vaccination or immunization using a prime-boost regimen
EP1372708B1 (en) * 2001-02-13 2008-06-18 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY Vaccine for transcutaneous immunization against travellers' diarrhoea
BRPI0408779A (pt) 2003-03-26 2006-04-04 Wyeth Corp uso de composições, composição imunogênica e kit
JP2007509040A (ja) 2003-10-11 2007-04-12 イネックス ファーマシューティカルズ コーポレイション 先天性免疫及び抗体依存性細胞傷害を強化するための方法及び組成物
US20050181035A1 (en) 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
WO2006017857A2 (en) 2004-08-13 2006-02-16 The Trustees Of The University Of Pennsylvania Antibiotic resistance free dna vaccines
EP2249843A4 (en) * 2008-02-24 2013-05-08 Us Gov Health & Human Serv USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOGENIC INFECTIONS
CA2719614C (en) 2008-03-25 2018-05-01 Juvaris Biotherapeutics, Inc. Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc)
US8251111B2 (en) 2008-09-18 2012-08-28 Premium Balloon Accessories, Inc. Balloon inflator
US8465748B2 (en) * 2009-03-30 2013-06-18 Matthias Giese Vaccine compositions and methods containing an immunogen derived from equine arteritis virus
SI2992899T1 (sl) * 2009-05-14 2020-10-30 Bayer Intellectual Property Gmbh Povečan imunski odziv pri ptičjih vrstah
NZ612285A (en) * 2010-12-22 2015-09-25 Bayer Ip Gmbh Enhanced immune response in bovine species
MX2016010993A (es) * 2014-02-28 2017-05-01 Bayer Animal Health Gmbh Plasmidos inmunoestimuladores.

Also Published As

Publication number Publication date
TW201718001A (zh) 2017-06-01
AR105568A1 (es) 2017-10-18
JP2018521109A (ja) 2018-08-02
EP3328424A1 (en) 2018-06-06
IL256984A (en) 2018-03-29
CL2018000253A1 (es) 2018-07-20
BR112018002107A2 (pt) 2018-09-25
AU2016302436A1 (en) 2018-02-15
AU2016302436B2 (en) 2022-03-03
MX2018001251A (es) 2018-03-26
US20180326049A1 (en) 2018-11-15
US11439703B2 (en) 2022-09-13
PH12018500201A1 (en) 2018-07-30
CN108025062A (zh) 2018-05-11
ZA201801338B (en) 2021-08-25
WO2017021266A1 (en) 2017-02-09
CA2993883A1 (en) 2017-02-09
KR20180036765A (ko) 2018-04-09
SG10202000891UA (en) 2020-03-30

Similar Documents

Publication Publication Date Title
IL250520A0 (en) arrangement in mortar
IL250818A0 (en) Methods and preparations for increasing immune responses
IL247614B (en) Methods and preparations for changing the immune response
GB201703211D0 (en) Title in foreign
HK1256161A1 (zh) 被褥的改進
IL259202A (en) Modified immune cells and their use
GB201701371D0 (en) Title in german
GB201512044D0 (en) Application in German
GB201504655D0 (en) Title in German
GB201521304D0 (en) Tokenisation in cardholder - not - present transactions
GB201521206D0 (en) Title in german
GB201521190D0 (en) Application in german
HK1255052A1 (zh) 豬科動物物種中增强的免疫應答
GB201603976D0 (en) Application in foreign
GB2564926B (en) Improvements in decorations
GB2537352B (en) Improvements in or relating to cases
GB201501253D0 (en) Title in foreign
GB201710673D0 (en) Title in foreign
GB201523035D0 (en) In terferometry
IL256947A (en) Enhanced immune response in aquatic species
GB201521191D0 (en) Application in german
GB201508643D0 (en) Improvements in shirts
GB201512116D0 (en) Title in german
GB201415791D0 (en) Improvements in frying technology
GB201505011D0 (en) Improvements in packages